The eight main blood types are A+, A-, B+, B-, O+, O-, AB+, and AB-. The most common blood type in the United States is O-positive, with around 38 percent of the population having this type of blood. However, blood type O-positive is more common in Latino-Americans than other ethnicities, with around 53 percent of Latino-Americans with this blood type, compared to 47 percent of African Americans and 37 percent of Caucasians. Blood donation The American Red Cross estimates that every two seconds someone in the United States needs blood or platelets, highlighting the importance of blood donation. It was estimated that in 2021, around 6.5 million people in the U.S. donated blood, with around 1.7 million of these people donating for the first time. Those with blood type O-negative are universal blood donors, meaning their blood can be transfused for any blood type. Therefore, this blood type is the most requested by hospitals. However, only about seven percent of the U.S. population has this blood type. Blood transfusion Blood transfusion is a routine procedure that involves adding donated blood to a patient’s body. There are many reasons why a patient may need a blood transfusion, including surgery, cancer treatment, severe injury, or chronic illness. In 2021, there were around 10.76 million blood transfusions in the United States. Most blood transfusions in the United States occur in an inpatient medicine setting, while critical care accounts for the second highest number of transfusions.

The most common blood type among the population in the United States is O-positive. Around 53 percent of the Latino-American population in the U.S. has blood type O-positive, while only around 37 percent of the Caucasian population has this blood type. The second most common blood type in the United States is A-positive. Around 33 percent of the Caucasian population in the United States has A-positive blood type. Blood type O-negative Those with blood type O-negative are universal donors as this type of blood can be used in transfusions for any blood type. O-negative blood type is most common in the U.S. among Caucasian adults. Around eight percent of the Caucasian population has type O-negative blood, while only around one percent of the Asian population has this blood type. Only around seven percent of all adults in the United States have O-negative blood type. Blood Donations The American Red Cross estimates that someone in the United States needs blood every two seconds. However, only around three percent of age-eligible people donate blood yearly. The percentage of adults who donated blood in the United States has not fluctuated much for the past two decades. In 2021, around 15 percent of U.S. adults donated blood, the same share reported in the year 2003.

According to Cognitive Market Research, the global blood group typing market size is USD XX million in 2023 and will expand at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

The global blood group typing market will expand significantly by 8.8% CAGR between 2024 to 2031.
North America held the major market of more than XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Europe accounted for a share of over XX% of the global market size of USD XX million.
Asia Pacific held a market of around XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Latin America's market will have more than XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Middle East and Africa held the major market of around XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
The blood group typing industry is set to rise due to increased blood group ownership rates, rising awareness regarding blood group health, accelerated R&D in the blood group typing industry, and the rise of E-commerce. Increasing online retail channels further bolster demand, while cultural significance and investment appeal contribute to its enduring popularity.
The blood group typing market is driven by rising awareness regarding blood group health, accelerated R&D in the blood group typing industry, and the rise of E-commerce.
Antibody Screenings are anticipated to form the majority of blood group owners in the years to come.

Current Scenario of the Blood Group Typing Market

Key Drivers of the Blood Group Typing Market

The growing incidence of chronic illnesses and the increase in surgical operations necessitates the need for blood donations

The demand for blood has grown as chronic diseases and the surgical procedures necessary to treat them have become more common. Blood transfusions are typically necessary for patients with chronic illnesses to manage their symptoms, and large volumes of blood are required for surgical procedures, particularly major surgeries, to ensure safe and effective results. As a result, the need for blood has steadily increased within the healthcare system, which has led to a rise in blood donation rates. The market is anticipated to benefit from this. To treat patients with chronic illnesses and those having difficult surgical operations, the American National Red Cross (2023) estimates that every day, over 29,000 units of red blood cells are required in US hospitals and emergency rooms. For instance, according to the National Center for Biotechnology Information, the number of people 50 years of age and older who have at least one chronic illness is predicted to rise from 71.522 million in 2020 to 142.66 million in 2050, a 99.5% increase.

Source- https://pubmed.ncbi.nlm.nih.gov/36711415/#:~:text=Of%20the%20population%2050%20years,to%2014.968%20million%20in%202050.

Blood group typing is a necessary test that establishes the Rh factor and the level of blood compatibility between the donor and the recipient prior to blood transfusions. Thus, the need for blood donations is a result of the rising prevalence of chronic illnesses and the rise in surgical procedures.

Blood Donation rates have necessitated the need for Blood Group Typing

Global blood donation rates have significantly increased over time. The need for transfusion procedures such as blood type detection and cross-matching has surged due to a rise in voluntary blood donations. The National Health Service Blood and Transplant (NHSBT) receives over 1.5 million voluntary blood donations annually, which are processed by the government before being given to hospitals and patients in need, according to an article published by the European Blood Alliance (EBA) (2019–2022).

Source- https://www.nhsbt.nhs.uk/who-we-are/a-history-of-donation-transfusion-and-transplantation/

NHSBT supplies hospitals in England with a secure and dependable supply of blood components, diagnostic services, and stem cell treatments. To do this, it depends on 1...

ABO Blood Type Test Kit Market Outlook

The global ABO blood type test kit market size was valued at USD 780 million in 2023 and is projected to reach USD 1.2 billion by 2032, growing at a CAGR of 4.8% during the forecast period. The market for ABO blood type test kits is experiencing robust growth primarily driven by increasing demand for blood transfusion services, advancements in diagnostic technologies, and the rising prevalence of chronic diseases necessitating blood type testing. These factors contribute significantly to the market's expansion and its optimistic outlook.

One of the primary growth factors for the ABO blood type test kit market is the increasing number of surgical procedures and trauma cases worldwide, which demand immediate and accurate blood typing. Additionally, the growing awareness about the importance of blood typing in organ transplantation and prenatal testing further propels the market. The surge in blood donation drives and the need for efficient blood bank management systems, which rely heavily on accurate blood type testing, also significantly contribute to market growth.

Technological advancements in diagnostic techniques, such as the development of rapid test kits that offer quick and reliable results, are another critical driver of market expansion. These innovations have made blood typing more accessible and convenient, particularly in remote and underserved areas. The rising adoption of point-of-care testing, which allows for blood type determination outside traditional laboratory settings, is also enhancing the market's growth prospects.

The increasing prevalence of chronic diseases, such as cancer and kidney disorders, which often require regular blood transfusions, is a significant factor fueling the demand for ABO blood type test kits. Moreover, the aging global population, which is more susceptible to various medical conditions requiring blood transfusions, contributes to the sustained demand for these kits. Public health initiatives and government policies promoting regular health check-ups and blood donation are also playing a crucial role in driving the market forward.

From a regional perspective, North America holds a dominant position in the ABO blood type test kit market due to its well-established healthcare infrastructure, high awareness levels, and significant investments in healthcare technologies. Europe follows closely, driven by similar factors along with a strong focus on research and development. The Asia Pacific region is expected to witness the fastest growth, attributed to its large population base, increasing healthcare expenditures, and rising awareness about blood-related health issues. Other regions, including Latin America and the Middle East & Africa, are also showing promising growth potential due to improving healthcare facilities and increasing government initiatives.

Product Type Analysis

The ABO blood type test kit market is segmented by product type into rapid test kits and laboratory test kits. Rapid test kits are designed for quick and efficient blood typing, providing results in a matter of minutes. These kits are particularly useful in emergency situations, field settings, and for point-of-care testing. The demand for rapid test kits is driven by their ease of use, minimal training requirements, and the ability to deliver immediate results, making them highly suitable for use in various non-laboratory settings.

Laboratory test kits, on the other hand, are designed for use in clinical laboratories and provide highly accurate and reliable results. These kits are typically used in hospitals, diagnostic laboratories, and blood banks where precision is crucial. The demand for laboratory test kits is driven by the increasing number of diagnostic procedures and the need for accurate blood type determination in critical medical situations. These kits often employ advanced technologies such as gel cards and microplates, contributing to their high accuracy and reliability.

The rapid test kits segment is expected to witness significant growth during the forecast period due to the increasing adoption of point-of-care testing and the rising need for quick and efficient blood type determination in emergency and remote settings. The convenience and speed offered by rapid test kits are making them increasingly popular among healthcare providers and individual consumers alike. Additionally, advancements in rapid testing technologies are further enhancing the accuracy and reliability of these kits, contributing to their growing demand.

ABO Blood Group Reagent Market Outlook

The global ABO blood group reagent market size is projected to witness significant growth from $820 million in 2023 to approximately $1.4 billion by 2032, with a compound annual growth rate (CAGR) of 6.2%. The primary growth drivers of this market include the rising prevalence of chronic diseases, increased demand for blood transfusions, and advancements in diagnostic technologies. As healthcare systems worldwide continue to improve and expand, the need for accurate blood typing and cross-matching becomes critical, further driving the market's expansion.

One of the pivotal factors driving the growth of the ABO blood group reagent market is the increasing incidence of chronic diseases and trauma cases requiring blood transfusions. With the aging global population, conditions such as cancer, cardiovascular diseases, and orthopedic surgeries are becoming more prevalent, necessitating frequent blood transfusions. This increases the demand for reliable ABO blood group reagents, which are essential for ensuring patient safety during transfusions. Additionally, increased awareness about blood donation and the safety of blood transfusions is contributing to the market's growth.

Advancements in diagnostic technologies and automated blood typing systems are also propelling the ABO blood group reagent market forward. Modern diagnostic laboratories and blood banks are adopting automated systems that offer high precision and efficiency in blood typing and cross-matching. These advancements reduce human errors, enhance throughput, and improve the overall quality of diagnostic services. The integration of advanced technologies such as artificial intelligence and machine learning in blood group typing is further expected to open new avenues for market growth.

Government initiatives and regulations promoting safe blood transfusion practices are another critical factor contributing to market growth. Stringent guidelines and protocols established by health authorities such as the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA) ensure the implementation of reliable and accurate blood typing and cross-matching procedures. These regulations mandate the use of high-quality reagents, thus driving the demand for ABO blood group reagents.

The regional outlook of the ABO blood group reagent market highlights significant growth potential in various parts of the world. North America and Europe are anticipated to dominate the market due to advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players. Asia Pacific is expected to witness the highest growth rate, driven by an expanding healthcare sector, increasing awareness about blood donation, and supportive government policies. Latin America and the Middle East & Africa regions also present growth opportunities due to improving healthcare access and rising investment in healthcare infrastructure.

Product Type Analysis

The ABO blood group reagent market is segmented by product type into Anti-A Reagents, Anti-B Reagents, Anti-AB Reagents, Anti-D Reagents, and Others. Anti-A reagents hold a prominent position in the market due to their critical role in determining the presence of A antigens in blood samples. These reagents are crucial for ensuring compatibility in blood transfusions and organ transplants. The increasing demand for accurate blood typing in hospitals and diagnostic laboratories is driving the growth of the Anti-A reagents segment.

Anti-B reagents are also witnessing substantial demand as they are essential for detecting B antigens in blood samples. Accurate determination of B antigens is vital for preventing adverse reactions during blood transfusions. The rising prevalence of conditions requiring blood transfusions, such as anemia and trauma, is contributing to the growth of the Anti-B reagents segment. Moreover, advancements in reagent formulations are enhancing the sensitivity and specificity of Anti-B reagents, further boosting their market adoption.

The Anti-AB reagents segment is gaining traction due to its importance in identifying AB blood group individuals. These reagents play a crucial role in blood typing, especially in emergency situations where rapid and accurate identification of blood groups is necessary. The increasing number of surgeries and medical procedures requiring

Overview

New York, NY – August 12 , 2025 : The Global Blood Bank Market is projected to reach US$ 26.1 Billion by 2034, up from US$ 17.8 Billion in 2024, at a CAGR of 3.9% from 2025 to 2034. In 2024, North America dominated with over 42.3% share, generating US$ 7.5 billion in revenue. The demand for safe and reliable blood products continues to grow globally. Advancements in blood transfusion technologies are boosting market growth. Blood banks remain essential for supplying hospitals with plasma, platelets, and red blood cells for various treatments and surgeries.

Growing incidences of chronic diseases, cancer, and trauma are driving the demand for efficient blood bank services. The aging population further increases the need for blood transfusions. Blood banks support critical medical procedures, from treating anemia and hemophilia to emergency trauma care. The market’s growth is also supported by improved healthcare infrastructure in developing regions. Governments and healthcare organizations are investing in better collection, testing, and storage facilities to meet rising blood product requirements.

Innovations in blood typing and cross-matching technologies are enhancing transfusion safety. These advancements improve compatibility between donors and recipients, reducing risks during procedures. Automated blood bank systems are becoming more common, streamlining the collection, testing, and storage processes. These systems improve operational efficiency and minimize human errors. The trend toward automation also supports faster response times in emergency situations. By adopting such technologies, healthcare providers can ensure better quality control and safer transfusions for patients.

A breakthrough in April 2024 by researchers from DTU and Lund University marked a major step in transfusion science. They discovered enzymes capable of removing specific sugars in the A and B antigens of the human ABO blood group system. This innovation could enhance compatibility in blood transfusions. Improved cross-matching techniques reduce transfusion-related risks and expand donor-recipient match possibilities. Such advancements are expected to revolutionize blood bank operations by increasing the availability of compatible blood for patients with rare blood types.

The adoption of blood bank management software is further transforming the market. These digital solutions optimize inventory management and ensure adequate supply levels at all times. They also improve traceability by enhancing data tracking from donation to transfusion. Continuous advancements in blood preservation techniques are extending shelf life and maintaining quality. With rising global healthcare needs, the market offers strong growth potential. Expanding donor bases, improving transfusion safety, and integrating advanced technologies remain key priorities for blood bank operators worldwide.

Blood Type Special Centrifuge Market Outlook

The global blood type special centrifuge market size was valued at approximately USD 1.2 billion in 2023 and is projected to reach nearly USD 2.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. This significant growth is driven by an increasing demand for precise blood component separation, rising incidences of blood disorders, and advancing healthcare infrastructure globally.

A major growth factor for the blood type special centrifuge market is the escalating prevalence of blood-related disorders and diseases. Conditions such as anemia, leukemia, and other hematological disorders necessitate the use of specialized centrifuges for accurate diagnosis and treatment. Additionally, the rising number of surgical procedures and the subsequent need for blood transfusions emphasize the importance of efficient blood separation techniques, further driving market demand. Furthermore, advancements in medical technology are enabling the development of more sophisticated and efficient centrifuges, which enhances their adoption in various healthcare settings.

Another critical growth factor is the expanding healthcare infrastructure, particularly in developing regions. Countries in Asia Pacific and Latin America are investing substantially in healthcare facilities and diagnostic laboratories, which in turn increases the demand for advanced medical equipment, including blood type special centrifuges. Additionally, government initiatives and funding aimed at improving healthcare access and quality are positively impacting market growth. For instance, numerous national health programs are focusing on better management of blood banks and transfusion services, which rely heavily on effective centrifugation processes.

The increased focus on research and development in the medical field is also a significant driver of market growth. Research laboratories and academic institutions are increasingly utilizing blood type special centrifuges for various analytical and experimental purposes. The rise in funding for medical research and the growing emphasis on personalized medicine are further contributing to the increasing demand for specialized centrifuges. Moreover, collaborations between universities and commercial entities are fostering innovation in centrifuge technology, leading to the introduction of advanced products in the market.

From a regional perspective, North America holds a substantial share of the blood type special centrifuge market, owing to its well-established healthcare infrastructure, high healthcare spending, and robust presence of key market players. Europe also represents a significant market share, driven by advanced healthcare facilities and increasing focus on research activities. The Asia Pacific region, however, is anticipated to witness the highest growth rate during the forecast period, driven by rapid healthcare advancements and increasing governmental support. This regional growth outlook highlights the global nature of the market's expansion and the diverse factors influencing it.

Product Type Analysis

The blood type special centrifuge market is segmented by product type, which includes benchtop centrifuges, floor-standing centrifuges, high-speed centrifuges, and low-speed centrifuges. Benchtop centrifuges are widely used in various healthcare and research settings due to their compact size and versatility. These centrifuges are particularly popular in smaller laboratories and clinics where space is a constraint. Their ease of use and affordability make them an attractive option for many facilities looking to enhance their diagnostic capabilities without significant financial investment.

Floor-standing centrifuges, on the other hand, are preferred in larger medical and research institutions that require higher capacity and performance. These centrifuges are designed to handle larger volumes of samples and offer superior speed and efficiency compared to benchtop models. The advancements in automation and digital integration in floor-standing centrifuges are driving their adoption in settings where high throughput and precision are critical. Additionally, these centrifuges are often equipped with advanced safety features, making them suitable for handling infectious or hazardous samples.

High-speed centrifuges are another key segment in the market, primarily used for applications requiring rapid separation of blood components. These centrifuges are capable of achieving very high rotational speeds, which significantly

In 2023, there were ****** people in the United States who had hemophilia A and around ***** people were diagnosed with hemophilia B. This statistic displays the number of people in the U.S. diagnosed with a blood disorder by disorder type, as of 2023.

The Global Arterial Blood Collection Devices Sales Market is expected to grow at a CAGR of 7.5% during the forecast period 2021-2028. The growth in this market can be attributed to the increasing incidence of chronic diseases, the rising number of hospitals and clinics, and the growing demand for blood transfusions.

Arterial blood collection devices are used for collecting arterial blood samples from patients. Arterial blood collection is a procedure in which a small amount of blood is taken from an artery for diagnostic testing. The most common type of arterial blood collection device is the syringe.

On the basis of Type, Global Arterial Blood Collection Devices Sales Market is segmented into Blood collection tubes, Lancet, Needles, Vacuum Blood Collection Systems, Microfluidic Systems, and Others.

Blood collection tubes:

Blood collection tubes are used to collect blood from a patient for transfusion, diagnosis, or research. They are made of plastic and have a rubber stopper at one end. The other end has a needle that is inserted into the vein of the patient. Once the required amount of blood is collected, the needle is removed and the stopper is pressed to seal the tube.

Lancet:

A lancet is a small, sharp, pointed blade that is used to puncture the skin. It is usually made of stainless steel or plastic. Lancets are used to collect small samples of blood from the finger or other parts of the body for diagnostic testing. They are also used to prick the skin to relieve itching and pain.

Needles:

Needles are thin, hollow tubes that are used to inject or withdraw fluids from the body. They are made of stainless steel or plastic and have a sharp point at one end. Needles are inserted into the vein or artery of the patient for transfusion, diagnosis, or research.

Vacuum blood collection systems:

A vacuum blood collection system is a device that is used to collect blood from a patient for transfusion, diagnosis, or research. It consists of a plastic tube with a rubber stopper at one end and a needle at the other. The needle is inserted into the vein of the patient and the required amount of blood is collected. The rubber stopper is then pressed to seal the tube.

Microfluidic systems:

Microfluidic systems are devices that are used to collect small samples of blood from the finger or other parts of the body for diagnostic testing. They consist of a plastic chip with channels and chambers that are used to isolate and study individual cells.

On the basis of Application, Global Arterial Blood Collection Devices Sales Market is segmented into Hospitals & clinics, Blood banks, Other.

Hospitals & clinics:

Hospitals and clinics are the largest users of arterial blood collection devices. They use these devices to collect blood from patients for transfusion, diagnosis, or research. Blood banks also use these devices to collect blood from donors for transfusion.

Blood banks:

Blood banks are the second-largest users of arterial blood collection devices. They use these devices to collect blood from donors for transfusion. Blood banks also use these devices to collect blood from patients for diagnosis or research.

On the basis of Region, Global Arterial Blood Collection Devices Sales Market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.

North America: The United States and Canada are the largest markets for arterial blood collection devices in North America. The growing number of hospitals and clinics, and the increasing demand for blood transfusions are the main drivers of market growth in this region.

Latin America: Latin America is expected to be the largest market for arterial blood collection devices during the forecast period. The rising prevalence of chronic diseases, such as diabetes and cancer, is expected to drive market growth in the region. In addition, the increasing number of surgical procedures being performed is also anticipated to fuel market demand.

Asia Pacific: The Asia Pacific is projected to be the fastest-growing market for arterial blood collection devices during the forecast period. The region's rapidly growing population and rising disposable incomes are major factors driving the market growth. In addition, the increasing number of hospitals and clinics in the region is also fuelling demand for these devices.

Middle East & Africa: The Middle Eas

The global blood type special centrifuge market is poised for significant growth, driven by increasing demand for accurate and efficient blood component separation in hospitals and blood banks. Technological advancements leading to higher-speed, more precise centrifuges with improved safety features are key drivers. The rising prevalence of blood-related disorders and the growing need for blood transfusions globally fuel market expansion. Furthermore, the increasing adoption of automation and sophisticated data management systems in blood banks is streamlining operations and improving efficiency, thereby boosting demand for advanced centrifuges. The market is segmented by application (hospital, blood center, other) and type (refrigerated, non-refrigerated). Hospitals currently hold the largest market share due to their high volume of blood processing needs. However, the blood center segment is expected to witness substantial growth fueled by increasing investment in infrastructure and technological upgrades within these facilities. The non-refrigerated segment is projected to grow at a faster rate due to its cost-effectiveness and ease of use, particularly in resource-constrained settings. Geographic expansion is another key aspect. North America and Europe currently dominate, but rapidly developing economies in Asia-Pacific, particularly China and India, present significant opportunities. Competitive landscape is characterized by established players like Meditech, Thomas Scientific, Grifols, and newer entrants, spurring innovation and enhancing product offerings. Challenges for market expansion include the high initial investment costs associated with advanced centrifuge systems and the stringent regulatory requirements surrounding medical devices. However, these challenges are being mitigated by technological advancements reducing costs and by manufacturers focusing on regulatory compliance. The forecast period (2025-2033) anticipates continued market expansion, driven by factors including increasing healthcare spending, growing awareness of blood safety, and the continuing development of innovative centrifugation technologies. This growth will be further propelled by the expansion of blood banks and hospitals, especially in emerging markets, and the growing focus on personalized medicine, necessitating more precise blood component separation techniques. The market is projected to witness a healthy CAGR, outpacing the general medical equipment market growth rate.

The global automatic blood grouping analyzer market is experiencing robust growth, driven by increasing prevalence of blood transfusion-related diseases, rising demand for accurate and rapid blood typing, and technological advancements leading to more efficient and automated systems. The market is segmented by application (hospitals, blood banks and transfusion centers, laboratories) and type (fully automatic, semi-automatic). Hospitals currently represent the largest segment, owing to the high volume of blood tests conducted in these settings. However, the blood banks and transfusion centers segment is projected to witness significant growth due to the increasing focus on efficient blood management and inventory control. Fully automatic analyzers dominate the market due to their higher throughput, reduced manual intervention, and improved accuracy compared to semi-automatic systems. This preference is expected to continue driving market expansion, particularly in developed regions like North America and Europe, where advanced medical infrastructure and high healthcare spending are prevalent. Technological innovations such as integration with laboratory information systems (LIS) and the development of analyzers with advanced features like automated sample preparation and result interpretation further contribute to market growth. Despite these positive trends, the market faces certain challenges. High initial investment costs associated with purchasing and maintaining advanced automatic blood grouping analyzers can be a barrier for smaller hospitals and laboratories, particularly in developing regions. Furthermore, the regulatory landscape surrounding medical devices varies across different countries, potentially impacting market penetration. Nevertheless, the long-term growth prospects for this market remain strong, fueled by increasing healthcare expenditure, expanding diagnostic testing facilities, and a growing awareness of the importance of accurate blood typing in ensuring safe blood transfusions. The market is expected to witness significant growth across Asia Pacific, driven by improving healthcare infrastructure and rising disposable incomes in countries like India and China. Companies such as Beckman Coulter, Ortho Clinical Diagnostics, and Grifols are major players in this market, competing on factors such as technology, cost-effectiveness, and after-sales service.

Snapshot img

Blood Market Size 2025-2029

The blood market size is forecast to increase by USD 2.6 billion, at a CAGR of 5.7% between 2024 and 2029. The market is experiencing significant growth, driven by the increasing number of hospitals and blood banks worldwide.

Major Market Trends & Insights

North America dominated the market and accounted for a 40% share in 2023. The market is expected to grow significantly in North America region as well over the forecast period. Based on the Product, the WBC and P segment led the market and was valued at USD 5.05 billion of the global revenue in 2023. Based on the End-user, the hospitals segment accounted for the largest market revenue share in 2023.

Market Size & Forecast

Market Opportunities: USD 8.18 Billion Future Opportunities: USD 2.6 Billion CAGR (2024-2029): 5.7% North America: Largest market in 2023

The market continues to evolve, driven by advancements in diagnostic technologies and growing applications across various sectors. Blood viscosity measurement and platelet aggregation studies are crucial in cardiovascular research, while blood volume determination and blood oxygen saturation monitoring are essential in anesthesiology. Blood flow dynamics and blood pressure regulation are key focuses in intensive care units. Thrombocytopenia assessment and erythropoiesis stimulation are vital in hematology, with ongoing research in blood clot formation and anticoagulation therapy. Blood storage techniques and blood lipid profile analysis are essential in blood banking. A blood chemistry panel, plasma protein levels, and blood cell morphology analysis are common diagnostic tools in clinical laboratories.

What will be the Size of the Blood Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

Blood rheology and blood transfusion protocols are significant in transfusion medicine. Hematopoiesis regulation and blood glucose monitoring are essential in oncology. Hemoglobinopathy screening, serum protein electrophoresis, and blood gas analysis are crucial in genetic disorders diagnosis. Blood coagulation factors and blood group antigens testing are vital in forensic science. For instance, a recent study showed a 20% increase in sales for a diagnostic company specializing in blood viscosity measurement technology. The global blood testing market is projected to grow by 7% annually, reflecting the continuous demand for advanced diagnostic tools and techniques. The blood screening products segment is the second largest segment of the product and was valued at USD 1.17 billion in 2023.

This expansion is fueled by a rising awareness of the importance of blood donation and the crucial role it plays in saving lives. However, challenges persist in ensuring adequate blood storage and transfusion facilities, particularly in rural areas. The scarcity of these essential facilities poses a significant obstacle to providing timely and effective blood transfusions, especially in regions with high demand but limited resources. Companies operating in the market must navigate these challenges to capitalize on the growing demand for blood and related services.

Strategic partnerships with hospitals and rural health clinics, as well as investments in advanced storage and transportation technologies, can help overcome these obstacles and expand market reach. By addressing these challenges, companies can effectively meet the growing demand for blood and related services, ensuring they remain competitive in the dynamic and evolving market.

How is this Blood Industry segmented?

The blood industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

WBC and P Blood screening products Blood typing products Source plasma collection

End-user

Hospitals Ambulatory surgical centers (ASCs) Others

Application

Therapeutic Diagnostic Research and development

Geography

North America

US Canada

Europe

France Germany Italy UK

APAC

China India Japan South Korea

Rest of World (ROW)

By Product Insights

The WBC and P segment is estimated to witness significant growth during the forecast period. The segment was valued at USD 5.05 billion in 2023. It continued to the largest segment at a CAGR of 4.55%.

The market witnesses continuous growth driven by the increasing demand for blood products in various medical applications. Whole blood, a key segment of the market, experiences steady expansion due to its usage in surgical procedures, blood transfusions, and trauma cases. Trauma is a leading global health issue, with the World Health Organization reporting that it causes over 5 million deaths and requires medical

North America Blood Glucose Monitoring Market size was valued at USD 8.1 Billion in 2024 and is projected to reach USD 13.92 Billion by 2032, growing at a CAGR of 7% from 2026 to 2032.

Key Market Drivers: Rising Prevalence of Diabetes: The North American blood glucose monitoring industry is an increase in diabetes prevalence. According to the Centers for Disease Control and Prevention (CDC), more than 30 million Americans had diabetes in 2021, with an additional 88 million pre-diabetic. Diabetes is so common that there is a great need for glucose monitoring devices to help people control their disease and avoid complications.

Technological Advancements in Glucose Monitoring Devices: Continuous glucose monitoring (CGM) technologies are pushing innovation in diabetes care by providing real-time, non-invasive options to users. The American Diabetes Association (ADA) reports that the number of persons utilizing CGMs has more than doubled in recent years. In 2021, more than 3.5 million Americans used CGMs, up from 1.5 million in 2017.

The global blood reinfusion system market is experiencing robust growth, driven by the increasing prevalence of trauma cases, advancements in surgical techniques, and a rising demand for minimally invasive procedures. The market, estimated at $2.5 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, reaching an estimated value of $4.2 billion by 2033. This growth is fueled by several key factors. Firstly, the escalating number of surgeries worldwide, particularly those involving significant blood loss, necessitates reliable and efficient blood reinfusion systems. Secondly, technological advancements are leading to the development of more sophisticated and user-friendly systems, improving both accuracy and efficiency in the process. Finally, a growing awareness among healthcare professionals about the benefits of blood reinfusion, including reduced transfusion risks and improved patient outcomes, is contributing significantly to market expansion. However, challenges remain, including the high cost of these systems, which may limit accessibility in certain regions, and the need for specialized training for effective operation. Segment-wise, the intraoperative system segment currently holds a larger market share due to its widespread use during surgeries. However, the postoperative system segment is anticipated to witness substantial growth over the forecast period owing to the rising demand for improved patient recovery and reduced post-operative complications. Geographically, North America and Europe are expected to dominate the market due to the high adoption rate of advanced medical technologies and well-established healthcare infrastructure. However, emerging economies in Asia-Pacific, particularly China and India, are showing promising growth potential due to increasing healthcare expenditure and expanding surgical capabilities. Key players like Zimmer Biomet, BD, 3T Medical, and Medtronic are driving innovation and competition, leading to continuous improvement in the technology and accessibility of blood reinfusion systems.

Blood Bank Labels Market Outlook

The global blood bank labels market size is projected to expand from USD 450 million in 2023 to USD 720 million by 2032, growing at a compound annual growth rate (CAGR) of 5.5%. This growth is driven by the increasing demand for accurate and reliable labeling solutions in blood banks and healthcare facilities. Rising incidences of blood disorders, growing awareness about safe blood transfusion practices, and technological advancements in label manufacturing are key drivers propelling the market forward.

One of the primary growth factors for the blood bank labels market is the increasing prevalence of blood-related disorders and diseases such as anemia, leukemia, and hemophilia. With a growing number of patients requiring blood transfusions, there is a heightened need for precise labeling to ensure the safety and efficacy of blood products. Additionally, the aging global population further contributes to the rising demand for blood products, thereby boosting the need for reliable labeling solutions.

Another significant factor contributing to market growth is the stringent regulatory framework surrounding blood transfusion and donation practices. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) mandate specific labeling requirements to ensure traceability, safety, and compliance. The implementation of these stringent regulations has led blood banks and healthcare facilities to adopt advanced labeling technologies to meet compliance standards, further driving market expansion.

Technological advancements in label manufacturing and printing technologies are also spurring market growth. Innovations such as Radio Frequency Identification (RFID) labels and barcode labels have revolutionized the way blood products are tracked and managed. These technologies offer enhanced traceability, reduce human errors, and improve overall efficiency in blood banks. The integration of such advanced labeling solutions is becoming increasingly common, thereby positively impacting market growth.

The regional outlook for the blood bank labels market indicates varying growth trends across different regions. North America is expected to dominate the market owing to the presence of advanced healthcare infrastructure and stringent regulatory frameworks. Europe follows closely due to similar regulatory standards and a high rate of blood donations. The Asia Pacific region is anticipated to witness significant growth due to increasing healthcare investments and rising awareness about blood donation. Latin America and the Middle East & Africa are also projected to grow, albeit at a slower pace, driven by improving healthcare facilities and growing awareness about safe blood transfusion practices.

Product Type Analysis

The blood bank labels market is segmented by product type into barcode labels, RFID labels, and others. Barcode labels are the most widely used type due to their cost-effectiveness and ease of implementation. These labels allow for efficient tracking and management of blood products, ensuring that each unit can be traced back to its donor. The simplicity and reliability of barcode labels make them a popular choice among blood banks and healthcare facilities.

RFID labels represent a more advanced segment within the blood bank labels market. These labels offer superior traceability and data storage capabilities compared to traditional barcode labels. RFID technology enables the storage of more detailed information about blood products, including donor information, collection date, and storage conditions. This advanced level of tracking significantly reduces the risk of errors and enhances the overall safety of blood transfusions, making RFID labels an increasingly popular choice.

The "others" category includes various types of labels that do not fall under barcode or RFID labels. This can include labels with special adhesive properties, tamper-evident labels, and labels designed for specific environmental conditions. These specialized labels are often used in niche applications, such as in extreme temperatures or where additional security is required. The demand for these specialized labels is growing as blood banks seek tailored solutions to meet specific needs.

Overall, the product type segment is characterized by a trend towards more advanced labeling solutions. While barcode labels remain the most commonly used due to their cost-effectiveness, the adoption of RFID labels is on the rise due to t